Isabelle Marie Bushnell, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1623 Hospital Loop, Owyhee, NV 89832 Phone: 775-757-2415 |
Danielle Mykita Houston Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1623 Hospital Loop, Owyhee, NV 89832 Phone: 775-757-2415 |
Nancy K Hammond, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1623 Hospital Loop, Owyhee, NV 89832 Phone: 775-757-2415 Fax: 775-757-3027 |
News Archive
Asuragen, Inc. and Life Technologies Corporation announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). Asuragen manufacturers the monitoring test, which is exclusively distributed by Life Technologies and runs on the company's Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument™.
The New York Times and Los Angeles Times report on specific hospitals that have been shown to be among the most expensive in the nation. Meanwhile, Modern Healthcare reports on interest from some senators in overhauling Medicare's hospital payment system.
A new study just released in the American Journal of Clinical Nutrition found that different flavors of peanuts – salted, spicy, honey-roasted, or unsalted – result in positive health benefits. The study, "A Randomized Trial on the Effects of Flavorings on the Health Benefits of Daily Peanut Consumption," was conducted at Purdue University and included over 150 men and women who incorporated peanuts into their daily diet for 12 weeks.
Among women with dense breast tissue, for whom traditional mammograms are less effective at detecting cancer, who request additional screening after a negative mammogram, abbreviated breast MRI may be a valuable cancer detection tool.
A new study from MIT reveals how cancer cells take some of their first steps away from their original tumor sites. This spread, known as metastasis, is responsible for 90 percent of cancer deaths.
› Verified 7 days ago